Population-based external validation of a competing-risks nomogram for patients with localized renal cell carcinoma

Journal of Clinical Oncology

Volumn 28, Issue 18, 2010, Pages

  Lughezzani, Giovanni ^a,b   Sun, Maxine ^a   Budäus, Lars ^a   Thuret, Rodolphe ^a   Perrotte, Paul ^a   Karakiewicz, Pierre I ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALIBRATION; CANCER DIAGNOSIS; CANCER MORTALITY; DIAGNOSTIC ACCURACY; HUMAN; KIDNEY CARCINOMA; LETTER; NOMOGRAM; POPULATION; PRIORITY JOURNAL; PROGNOSIS; RISK; VALIDITY; CANCER REGISTRY; CAUSE OF DEATH; COMORBIDITY; KIDNEY TUMOR; MORTALITY; NOTE; PATHOLOGY; RISK FACTOR; SURVIVAL RATE; VALIDATION STUDY;

CARCINOMA, RENAL CELL; CAUSE OF DEATH; COMORBIDITY; HUMANS; KIDNEY NEOPLASMS; NOMOGRAMS; RISK FACTORS; SEER PROGRAM; SURVIVAL RATE; VALIDATION STUDIES AS TOPIC;

EID: 77954585838     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2009.27.6345     Document Type: Letter

References (11)

1. Kutikov A, Egleston BL, Wong YN, et al: Evaluating overall survival and competing risks of death in patients with localized renal cell carcinoma using a comprehensive nomogram. J Clin Oncol 28:311-317, 2010
2. Altman DG, Royston P: What do we mean by validating a prognostic model? Stat Med 19:453-473, 2000
3. Vergouwe Y, Steyerberg EW, Eijkemans MJ, et al: Validity of prognostic models: When is a model clinically useful? Semin Urol Oncol 20:96-107, 2002
4. Bleeker SE, Moll HA, Steyerberg EW, et al: External validation is necessary in prediction research: A clinical example. J Clin Epidemiol 56:826-832, 2003 (Pubitemid 37162656)
5. Harrell FE Jr, Lee KL, Mark DB: Multivariable prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15:361-387, 1996 (Pubitemid 26072233)
6. Harrell FE: Regression modeling strategies: With applications to linear models, logistic regression, and survival analysis. New York, NY, Springer, 2001
7. Stephenson AJ, Scardino PT, Eastham JA, et al: Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Clin Oncol 23:7005-7012, 2005
8. Shariat SF, Walz J, Roehrborn CG, et al: External validation of a biomarker-based preoperative nomogram predicts biochemical recurrence after radical prostatectomy. J Clin Oncol 26:1526-1531, 2008
9. Karakiewicz PI, Briganti A, Chun FK, et al: Multi-institutional validation of a new renal cancer-specific survival nomogram. J Clin Oncol 25:1316-1322, 2007 (Pubitemid 46706877)
10. Ferrone CR, Kattan MW, Tomlinson JS, et al: Validation of a postresection pancreatic adenocarcinoma nomogram for disease-specific survival. J Clin Oncol 23:7529-7535, 2005 (Pubitemid 46291816)
11. Specht MC, Kattan MW, Gonen M, et al: Predicting nonsentinel node status after positive sentinel lymph biopsy for breast cancer: Clinicians versus nomogram. Ann Surg Oncol 12:654-659, 2005 (Pubitemid 41126095)